HCG and Oestradiol: Why HCG Raises Oestrogen on a Steroid Cycle and How to Manage It

HCG and oestradiol have a relationship that most UK steroid users do not understand, and misunderstanding it leads to the single most common dosing mistake in ancillary management: taking more AI to fix high oestrogen that the AI cannot fully reach. This guide explains exactly why HCG raises oestradiol on a steroid cycle, where the oestradiol is being produced, why aromatase inhibitors only partially control it, how to dose HCG to minimise the oestrogen spike without sacrificing testicular function, and what your bloodwork should look like when HCG and oestradiol are properly managed. Available from Intex Pharma UK, Intex Pharma HCG 5000IU is an essential on-cycle compound, but only when dosed correctly to balance testicular stimulation against the oestradiol increase it produces.

If you have ever run HCG alongside testosterone and an aromatase inhibitor, seen your oestradiol come back elevated on bloodwork despite the AI, and responded by increasing the AI dose only to crash your oestrogen and feel terrible, this guide explains what went wrong. The problem was not insufficient AI. The problem was that HCG and oestradiol production occur partly inside the testes, in a compartment where oral aromatase inhibitors have limited penetration. Understanding this mechanism changes how you dose both HCG and AI on a steroid cycle.

The Mechanism: How HCG Produces Oestradiol Inside the Testes

HCG binds to LH/CG receptors on Leydig cells, stimulating them to produce testosterone. This intratesticular testosterone (ITT) is produced at concentrations 50 to 100 times higher than serum levels. Within the testicular environment, aromatase enzyme is also present in Leydig cells, Sertoli cells and the interstitial tissue. This intratesticular aromatase converts a portion of the locally produced testosterone into oestradiol.

The critical point is location. When testosterone is produced in the testes by HCG stimulation, the aromatase conversion to oestradiol happens inside the testicular compartment before the testosterone enters systemic circulation. Oral aromatase inhibitors like Anastrozole and Letrozole work systemically: they circulate through the blood and inhibit aromatase in peripheral tissues (adipose tissue, liver, muscle). Their penetration into the intratesticular compartment is limited by the blood-testis barrier, which restricts the passage of many drugs from the bloodstream into the seminiferous tubules and interstitial spaces of the testes.

This means that when HCG stimulates intratesticular testosterone production, the resulting intratesticular oestradiol is produced in a compartment that your AI partially cannot reach. No matter how much Anastrozole you take, a proportion of the HCG-driven oestradiol will still be produced because the aromatase activity inside the testes is not fully suppressed by systemic AI dosing. Increasing the AI dose to try to control this oestradiol suppresses peripheral aromatase further (crashing oestrogen in every tissue except the testes), which produces the joint pain, fatigue, mood disruption and lipid damage of crashed oestradiol while the intratesticular source continues producing oestrogen regardless.

Why Increasing AI Dose Is the Wrong Response to HCG-Driven Oestradiol

The typical mistake follows a predictable pattern. A user runs testosterone at 300 to 500mg per week with HCG at 1,000 to 1,500IU twice weekly. Mid-cycle bloodwork shows oestradiol at 250 to 350 pmol/L (elevated). The user increases Anastrozole from 0.5mg twice weekly to 1mg twice weekly. The next blood draw shows oestradiol has dropped, but the user now has joint pain, low mood, dry skin and fatigue: the symptoms of crashed oestrogen in peripheral tissues. Oestradiol on bloodwork may even appear “in range,” but the user feels terrible because the AI has over-suppressed peripheral oestrogen while the intratesticular source continues dripping oestradiol into the serum, creating a misleading number on the lab report.

The correct response is not more AI. The correct response is less HCG. Reducing the HCG dose from 1,000 to 1,500IU per injection down to 250 to 500IU per injection directly reduces the intratesticular testosterone production, which directly reduces the intratesticular oestradiol that the AI cannot fully control. The lower HCG dose still maintains Leydig cell function and testicular volume (250IU is sufficient for both) while producing significantly less oestradiol. The AI dose can then remain at a conservative level that manages peripheral aromatisation without crashing oestrogen systemically.

How to Read Oestradiol Bloodwork When Running HCG

The relationship between HCG and oestradiol makes bloodwork interpretation more nuanced than on a testosterone-only cycle. On testosterone alone without HCG, oestradiol is produced entirely through peripheral aromatisation, which AI controls effectively. The oestradiol number on your blood test reflects a single, AI-manageable source. When you add HCG, the oestradiol number on your blood test reflects two sources: peripheral aromatisation (AI-controllable) plus intratesticular aromatisation (partially AI-resistant). This means a given oestradiol reading on bloodwork with HCG does not mean the same thing as the same reading without HCG.

The last scenario in the table above is the one that causes the most confusion and the most unnecessary suffering. Users see oestradiol “in range” on bloodwork and cannot understand why they feel awful. What is actually happening is that the intratesticular oestradiol source (from HCG) is propping up the total number on the lab report while the peripheral oestradiol (the oestrogen that actually matters for joints, brain, cardiovascular function and mood) has been crushed by excessive AI. The lab number looks fine; the user’s body is in oestrogen deprivation everywhere except inside the testes. For the full oestradiol testing protocol using the sensitive LC-MS/MS assay, see the testosterone bloodwork interpretation guide.

The Optimal HCG and Oestradiol Balance: A Practical Protocol

Why Intratesticular Oestradiol Is Not Entirely Bad

The instinct to suppress all oestradiol is itself a problem. Intratesticular oestradiol produced by HCG-driven aromatase activity has a physiological function: it supports germ cell proliferation, differentiation and the final maturation of spermatids. Oestradiol inside the testes is not a side effect to be eliminated; it is a component of normal testicular function that HCG is maintaining. For steroid users interested in fertility preservation, this intratesticular oestradiol is actually part of the mechanism by which HCG maintains spermatogenesis during exogenous androgen use. Suppressing it aggressively with high-dose AI could impair the very fertility that HCG is designed to protect. For the full fertility preservation protocol, see the guide on HCG and fertility preservation during a steroid cycle.

The goal is not to eliminate oestradiol. The goal is to keep total serum oestradiol within a range that does not produce symptoms (gynecomastia, excessive water retention, mood disruption) while allowing the intratesticular component to perform its physiological role. Lower HCG doses (250 to 500IU) achieve this balance far more effectively than high HCG doses combined with aggressive AI use.

Leydig Cell Desensitisation: What Happens When HCG Dose Is Too High for Too Long

A concern frequently raised in bodybuilding forums is Leydig cell desensitisation from excessive HCG use. The mechanism is real but often overstated. Chronic stimulation with very high HCG doses (above 2,500IU per injection) can downregulate LH/CG receptor density on Leydig cells, reducing their responsiveness to both HCG and natural LH. This is dose-dependent and duration-dependent: lower doses (250 to 500IU) used for standard on-cycle protocols do not produce clinically meaningful desensitisation in the timeframes relevant to typical steroid cycles (12 to 20 weeks).

The practical takeaway is that HCG at 250 to 500IU two to three times per week is the sweet spot that avoids both problems: it is high enough to maintain testicular function, low enough to avoid excessive oestradiol production, and moderate enough to prevent Leydig cell desensitisation across the duration of a standard cycle. Users who run HCG at 1,500 to 2,500IU per injection “because more is better” are producing more oestradiol, spending more money and potentially damaging the very Leydig cells they are trying to preserve. For full pre-cycle bloodwork guidance and the complete PCT protocol with HCG and Clomid, follow the linked guides.

HCG and Oestradiol: Frequently Asked Questions